Panel discussion: Practical considerations around utilizing BCMA-targeting agents in elderly patients in the real-world – access, eligibility, administration and convenience

Panelist(s)

• 

  Rakesh Popat, MD, PhD

  Consultant Haematologist & Associate Professor
  University College London Hospitals NHS Foundation Trust
  LONDON, England, United Kingdom
• 

  Suzanne Lentzsch, MD, PhD (she/her/hers)

  Professor of Medicine
  Columbia University, New York, United States
• 

  Adam D. Cohen, MD

  Associate Professor
  Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
  Philadelphia, Pennsylvania, United States
• 

  Meletios A. Dimopoulos, MD

  Professor and Chairman of the Department of Clinical Therapeutics
  National and Kapodistrian University of Athens, Greece